Airbus (AIR FP) has offered to divest some assets in order to secure European regulatory support for the space merger with Leonardo (LDO IM) and Thales (HO FP), FT reports citing sources

Remedy offers of this kind are the standard second act in European cross-border consolidations where the combined entity would concentrate market share in a strategically sensitive sector: the Commission signals concerns in Phase I or opens an in-depth review, and the parties pre-empt a prohibition or an onerous decision by volunteering divestitures before the clock forces the issue. The space and defence peer set adds a layer beyond pure competition analysis, since national governments hold golden-share-style interests and industrial-policy stakes in all three parties, which historically has shaped which assets are deemed carveable and who is an acceptable buyer. The sequencing worth noting is that behavioural concessions rarely suffice in mergers of this profile; structural remedies, meaning actual asset sales with a credible purchaser, are what have secured clearance in comparable defence and aerospace tie-ups. Key follow-ons are whether the offer is made in Phase I or after an in-depth investigation is opened, the identity and financing of any divestiture buyer, and the reaction of the national stakeholders whose approval sits alongside Brussels. A source-based FT report of this kind typically precedes formal confirmation, so the tell is whether the companies or the Commission validate the framing in subsequent sessions.